Unknown

Dataset Information

Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO).


ABSTRACT:

Background

Percutaneous coronary intervention (PCI) for chronic total coronary occlusions (CTO) improves clinical symptoms and quality of life. The longer-term safety of PCI compared to optimal medical therapy (OMT) remains uncertain.

Aims

We sought to evaluate the long-term safety of PCI for CTO in a randomised trial as compared to OMT.

Methods

A total of 396 patients with a symptomatic CTO were enrolled into a randomised, multicentre clinical trial comparing PCI and OMT. Half of the patients had a single CTO; the others had multivessel disease. Non-CTO lesions were treated prior to randomisation (2:1 ratio). During follow-up, crossover from OMT to PCI occurred in 7.3% (1 year) and 17.5% (3 years) of patients.

Results

At 3 years, the incidence of cardiovascula

SUBMITTER: Werner GS 

PROVIDER: S-EPMC10493774 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature